Research

Long Shifts Lead to Nurse Burnout and Dissatisfied Patients

November 6, 2012

Amy Witkoski Stimpfel of the School of Nursing is quoted about a nurse-burnout study.

Article Source: Science Daily

Chubby Mice Show Why Midnight Snacking Makes Us Fat

November 13, 2012

Georgios Paschos of the Perelman School of Medicine is cited for research about the effects of eating late at night.

Article Source:
facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658November 14, 2012

Penn Study: Targeting Downstream Proteins in Cancer-Causing Pathway Shows Promise in Cell, Animal Model

PHILADELPHIA — The cancer-causing form of the gene Myc alters the metabolism of mitochondria, the cell’s powerhouse, making it dependent on the amino acid glutamine for survival. In fact, 40 percent of all “hard-to-treat” cancers have a mutation in the Myc gene.

Accordingly, depriving cells of glutamine selectively induces programmed cell death in cells overexpressing mutant Myc.

facebook twitter google print email
Media Contact:Jill DiSanto | jdisanto@upenn.edu | 215-898-4820November 9, 2012

Penn Social Policy & Practice Researcher Studies Homelessness and Academic Achievement

PHILADELPHIA -- One million American school children are homeless each year, and many more are thought to move frequently.  A researcher from the University of Pennsylvania’s School of Social Policy & Practice is the lead author on a new longitudinal study linking homelessness and frequent moving with children’s achievement.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194November 9, 2012

A Comparative Medicine Study by Penn Vet Identifies a New Approach to Combat Viral Infections

PHILADELPHIA — When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. Interferon can also play a role in suppressing tumor growth and the effects of autoimmune diseases, and doctors may use an artificial form of interferon to treat patients with certain cancers or multiple sclerosis. But even this approach sometimes fails when patients’ bodies reject the foreign interferon or growing resistant to its effects.

Penn Scientists Develop Novel Treatment for Serious Illness

November 4, 2012

Marina Cuchel and Daniel Rader of the Perelman School of Medicine are quoted about helping develop a treatment for rare heart conditions.

Article Source: Philly.com

How to Reduce Workplace Gender Segregation and Help Women Obtain Higher Paying Jobs

November 5, 2012

Matthew Bidwell of the Wharton School is cited for his collaborative paper “Do Women Choose Different Jobs From Men? Mechanics of Application Segregation in the Market for Managerial Workers.”

Article Source: Forbes
facebook twitter google print email
Media Contact:Jill DiSanto | jdisanto@upenn.edu | 215-898-4820November 2, 2012

Looking at the Big Picture: Penn Researcher Receives Grant to Study Success at Minority-serving Institutions

Panoramic images enable one to see everything in one complete picture, providing a better understanding of the entire setting.

And when looking at the landscape of higher education and student success, the viewer has to be able to see more than just a snapshot of public and private schools.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194November 2, 2012

At the World Resources Forum in Beijing, Penn’s Iliana Sepúlveda Shares Lessons on Energy Subsides

PHILADELPHIA — To a room full of academics and Ph.D. students in the notoriously polluted city of Beijing, the University of Pennsylvania’s Iliana Sepúlveda presented ideas for increasing the use of energy-efficient technology that may one day help lessen the burden of fossil-fuel combustion in that city, as well as many others across the globe.

facebook twitter google print email
Media Contact:Jessica Mikulski | jessica.mikulski@uphs.upenn.edu | 215-349-8369November 2, 2012

Penn Study Finds New Medication Shows Promise as Lipid-Lowering Therapy for Cholesterol Disorder

PHILADELPHIA — An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder.